GLDC mitigated by miR-30e regulates cell proliferation and tumor immune infiltration in TNBC

BackgroundTNBC, whose clinical prognosis is poorer than other subgroups of breast cancer, is a malignant tumor characterized by lack of estrogen receptors, progesterone hormone receptors, and HER2 overexpression. Due to the lack of specific targeted drugs, it is crucial to identify critical factors...

Full description

Bibliographic Details
Main Authors: Huaying Xie, Tingting Yan, Xinxin Lu, Yueyao Du, Shuguang Xu, Yu Kong, Liangjie Yu, Jian Sun, Liheng Zhou, Jun Ma
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1033367/full
_version_ 1811227043793207296
author Huaying Xie
Tingting Yan
Xinxin Lu
Yueyao Du
Shuguang Xu
Yu Kong
Liangjie Yu
Jian Sun
Liheng Zhou
Jun Ma
author_facet Huaying Xie
Tingting Yan
Xinxin Lu
Yueyao Du
Shuguang Xu
Yu Kong
Liangjie Yu
Jian Sun
Liheng Zhou
Jun Ma
author_sort Huaying Xie
collection DOAJ
description BackgroundTNBC, whose clinical prognosis is poorer than other subgroups of breast cancer, is a malignant tumor characterized by lack of estrogen receptors, progesterone hormone receptors, and HER2 overexpression. Due to the lack of specific targeted drugs, it is crucial to identify critical factors involved in regulating the progression of TNBC.MethodsWe analyzed the expression profiles of TNBC in TCGA and the prognoses values of GLDC. Correlations of GLDC and tumor immune infiltration were also identified. CCK8 and BrdU incorporation assays were utilized to determine cell proliferation. The mRNA and protein levels were examined by using Real-time PCR and Western blot analysis.ResultsIn the present study, we analyzed the mRNA expression profiles of TNBC in TCGA and found that GLDC, a key enzyme in glycine cleavage system, was significantly up-regulated in TNBC tissues and higher expression of GLDC was correlated with a worse prognosis in TNBC. Moreover, the expression of GLDC was negatively correlated with macrophage and monocyte and positively correlated with activated CD4 T cell and type 2 T helper cell in TNBC. Overexpression of GLDC facilitated the proliferation of TNBC cells, whereas GLDC knockdown had the opposite effects. Additionally, miR-30e acts as a functional upstream regulator of GLDC and the inhibitory effects of miR-30e on cell proliferation were mitigated by the reintroduction of GLDC.ConclusionsThese results imply that miR-30e-depressed GLDC acts as a tumor suppressive pathway in TNBC and provides potential targets for the treatment of TNBC.
first_indexed 2024-04-12T09:34:31Z
format Article
id doaj.art-9cca67cd04c442239b904ba24966df72
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-12T09:34:31Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-9cca67cd04c442239b904ba24966df722022-12-22T03:38:15ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-10-011310.3389/fimmu.2022.10333671033367GLDC mitigated by miR-30e regulates cell proliferation and tumor immune infiltration in TNBCHuaying Xie0Tingting Yan1Xinxin Lu2Yueyao Du3Shuguang Xu4Yu Kong5Liangjie Yu6Jian Sun7Liheng Zhou8Jun Ma9Department of Radiation Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Breast Surgery, School of Medicine, Renji Hospital, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Oncology, Ganzhou Women and Children’s Health Care Hospital, Ganzhou, ChinaDepartment of Breast Surgery, School of Medicine, Renji Hospital, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Breast Surgery, School of Medicine, Renji Hospital, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Radiation Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Radiation Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Breast Surgery, Obstetrics and Gynaecology Hospital, Fudan University, Shanghai, ChinaDepartment of Breast Surgery, School of Medicine, Renji Hospital, Shanghai Jiao Tong University, Shanghai, ChinaEye Institute, Eye & Ear, Nose, and Throat (ENT) Hospital, Shanghai Medical College, Fudan University, Shanghai, ChinaBackgroundTNBC, whose clinical prognosis is poorer than other subgroups of breast cancer, is a malignant tumor characterized by lack of estrogen receptors, progesterone hormone receptors, and HER2 overexpression. Due to the lack of specific targeted drugs, it is crucial to identify critical factors involved in regulating the progression of TNBC.MethodsWe analyzed the expression profiles of TNBC in TCGA and the prognoses values of GLDC. Correlations of GLDC and tumor immune infiltration were also identified. CCK8 and BrdU incorporation assays were utilized to determine cell proliferation. The mRNA and protein levels were examined by using Real-time PCR and Western blot analysis.ResultsIn the present study, we analyzed the mRNA expression profiles of TNBC in TCGA and found that GLDC, a key enzyme in glycine cleavage system, was significantly up-regulated in TNBC tissues and higher expression of GLDC was correlated with a worse prognosis in TNBC. Moreover, the expression of GLDC was negatively correlated with macrophage and monocyte and positively correlated with activated CD4 T cell and type 2 T helper cell in TNBC. Overexpression of GLDC facilitated the proliferation of TNBC cells, whereas GLDC knockdown had the opposite effects. Additionally, miR-30e acts as a functional upstream regulator of GLDC and the inhibitory effects of miR-30e on cell proliferation were mitigated by the reintroduction of GLDC.ConclusionsThese results imply that miR-30e-depressed GLDC acts as a tumor suppressive pathway in TNBC and provides potential targets for the treatment of TNBC.https://www.frontiersin.org/articles/10.3389/fimmu.2022.1033367/fullTNBCGLDCproliferationmiR-30etumor immune
spellingShingle Huaying Xie
Tingting Yan
Xinxin Lu
Yueyao Du
Shuguang Xu
Yu Kong
Liangjie Yu
Jian Sun
Liheng Zhou
Jun Ma
GLDC mitigated by miR-30e regulates cell proliferation and tumor immune infiltration in TNBC
Frontiers in Immunology
TNBC
GLDC
proliferation
miR-30e
tumor immune
title GLDC mitigated by miR-30e regulates cell proliferation and tumor immune infiltration in TNBC
title_full GLDC mitigated by miR-30e regulates cell proliferation and tumor immune infiltration in TNBC
title_fullStr GLDC mitigated by miR-30e regulates cell proliferation and tumor immune infiltration in TNBC
title_full_unstemmed GLDC mitigated by miR-30e regulates cell proliferation and tumor immune infiltration in TNBC
title_short GLDC mitigated by miR-30e regulates cell proliferation and tumor immune infiltration in TNBC
title_sort gldc mitigated by mir 30e regulates cell proliferation and tumor immune infiltration in tnbc
topic TNBC
GLDC
proliferation
miR-30e
tumor immune
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.1033367/full
work_keys_str_mv AT huayingxie gldcmitigatedbymir30eregulatescellproliferationandtumorimmuneinfiltrationintnbc
AT tingtingyan gldcmitigatedbymir30eregulatescellproliferationandtumorimmuneinfiltrationintnbc
AT xinxinlu gldcmitigatedbymir30eregulatescellproliferationandtumorimmuneinfiltrationintnbc
AT yueyaodu gldcmitigatedbymir30eregulatescellproliferationandtumorimmuneinfiltrationintnbc
AT shuguangxu gldcmitigatedbymir30eregulatescellproliferationandtumorimmuneinfiltrationintnbc
AT yukong gldcmitigatedbymir30eregulatescellproliferationandtumorimmuneinfiltrationintnbc
AT liangjieyu gldcmitigatedbymir30eregulatescellproliferationandtumorimmuneinfiltrationintnbc
AT jiansun gldcmitigatedbymir30eregulatescellproliferationandtumorimmuneinfiltrationintnbc
AT lihengzhou gldcmitigatedbymir30eregulatescellproliferationandtumorimmuneinfiltrationintnbc
AT junma gldcmitigatedbymir30eregulatescellproliferationandtumorimmuneinfiltrationintnbc